|
The Vaccine and Infectious Disease Organization is a non-profit organization owned by the University of Saskatchewan and operates with financial support from the governments of Saskatchewan and Alberta as well as Government of Canada and industry competitive grants. In addition to the facility on campus, VIDO also operates a research station. VIDO is a member of three National Networks of Centres of Excellence: the Canadian Bacterial Diseases Network, the Canadian Network for Vaccines and Immunotherapeutics (CANVAC), and PrioNet. It has created three spin-off companies (Biostar, Biowest, and Star Biotech) and has worked with start-up companies including PharmaDerm Laboratories, Taiga Bioactivities, Vetrepharm Canada Inc. and Inimex Veterinary Research. ==History== Initially called the Veterinary Infectious Disease Organization, VIDO was established with funding from the Devonian Group of Charitable Foundations, the Province of Alberta and the Province of Saskatchewan. VIDO had strong ties to the University of Saskatchewan’s Western College of Veterinary Medicine. In March 2003, VIDO’s name was changed to the Vaccine and Infectious Disease Organization. In October a new expansion was completed. In March 2004, VIDO received funding for the construction of a $140 million Biosafety Level 3 laboratory, the International Vaccine Centre (InterVac) for research into emerging and persistent human and animal diseases. Funding for the InterVac facility was provided by Government of Canada, the Canada Foundation for Innovation, the Government of Saskatchewan, the University of Saskatchewan, and the City of Saskatoon. InterVac finished construction in 2011 and is undergoing commissioning, scheduled for completion in Spring of 2012. VIDO/InterVac is one of the largest Containment Level 3 facilities in North America. It is one of the few Level 3 facilities in the world capable of working with large animals. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Vaccine and Infectious Disease Organization」の詳細全文を読む スポンサード リンク
|